Friday, September 30, 2022

Covid 19 damages the circulatory system

Results of clinical research published19 Sep 2022: 

Clinical Perspective

What Is New?

  • In a cohort study of 48 million adults in England and Wales, COVID-19 was associated with substantial excess incidence of both arterial thromboses and venous thromboembolism, which declined with time from COVID-19 diagnosis.

  • Excess incidence was higher, for a longer time, after hospitalized than non-hospitalized COVID-19.

  • There were an estimated 10 500 excess arterial thromboses and venous thromboembolic events after 1.4 million COVID-19 diagnoses.

What Are the Clinical Implications?

  • Strategies to prevent vascular events after COVID-19 are particularly important after severe COVID-19 leading to hospitalization and should include an early review in primary care and risk factor management.

  • After severe COVID-19, individuals at high risk of vascular events should be prescribed preventive therapies and counseled about the importance of adherence to them.

  • New simple treatment strategies to reduce infection-associated venous thromboembolism and arterial thromboses are needed.

Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales
Rochelle KnightVenexia WalkerSamantha Ip, and others

Originally published
19 Sep 2022
Circulation. 2022;146:892–906

No comments:

Post a Comment